RYHIX vs. MDT

In the year-to-date period, RYHIX achieves a -2.18% return, which is significantly lower than MDT's 4.70% return. Over the past 10 years, RYHIX has outperformed MDT with an annualized return of 5.21%, while MDT has yielded a comparatively lower 3.33% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Rydex Health Care Fund (RYHIX) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RYHIX Sharpe Ratio is -0.21, which is lower than the MDT Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of RYHIX and MDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RYHIX has not paid dividends to shareholders, while MDT's dividend yield for the trailing twelve months is around 3.37%.

The maximum RYHIX drawdown since its inception was -41.27%, smaller than the maximum MDT drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for RYHIX and MDT.

The current volatility for Rydex Health Care Fund (RYHIX) is 6.93%, while Medtronic plc (MDT) has a volatility of 7.35%. This indicates that RYHIX experiences smaller price fluctuations and is considered to be less risky than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.